The professor notes that the committee itself points out that the scientific data for the additional benefit from the fourth dose do not exist and therefore the relevant suggestion should not be made at this time.
His disagreement with her decision National Vaccination Committee for vaccination and in people aged 30 to 59 years, he says Professor Elias Mosialosas it states in its post, the relevant suggestion “is not accompanied by the necessary documentation”.
Mr. Mosialos notes that the committee itself points out that the scientific data on the additional benefit from the fourth installment do not exist and therefore the relevant suggestion should not be made this time period.
“Public health decisions and medical decisions must be based on documentation and systematic data analysis. In our country we need to have sufficient data on the percentage of our compatriots who have adequate immune protection. “, the professor emphasizes. It proposes random sampling to the general population, so that there is sufficient data on the percentage of citizens with adequate immunoprotection.
The whole post of the teacher
The National Vaccination Committee has done important work during the pandemic. However, her current suggestion for the administration of the second booster dose to people aged 30-59 who do not belong to the vulnerable categories is not accompanied by the necessary documentation.
In particular, the committee itself points out ‘that there is currently insufficient scientific data on the additional benefit of a second booster dose with existing vaccines.’
If there is not enough scientific data then the relevant suggestion should not be made at this time.
Some have indicated that those who are afraid will be able to take the fourth dose. Of course, this is not a sufficient reason to justify a policy, especially when there is insufficient documentation.
Public health decisions and medical decisions must be based on documentation and systematic data analysis. In our country we need to have sufficient data on the percentage of our compatriots who have adequate immunoprotection. This can be done by random sampling in the general population.
This will allow us to draw safer conclusions about the possible effects of the pandemic in the coming months but also about the need for booster doses.
Finally, I would like to point out that existing vaccines are still very effective in preventing serious disease. They are no longer very effective in preventing mild infections and re-infections. And this is especially true for Omicron sub-variants B4 and B5.
Check out the news feed and stay up to date with the latest news.
I have worked in the news industry for over 10 years. I have a vast amount of experience in covering health news. I am also an author at News Bulletin 247. I am highly experienced and knowledgeable in this field. I am a hard worker and always deliver quality work. I am a reliable source of information and always provide accurate information.
